Thoratec Seeks Therapeutic VAD, Others Aim For Alternative-To-Transplant

Thoratec plans to file a PMA supplement for a therapeutic recovery indication for the Thoratec ventricular assist device (VAD) by year-end.

More from Archive

More from Medtech Insight